DeutschNewstral
Article
bizjournals.com on 2016-01-28 13:09
Novartis replaces Alcon CEO, restructures its business
Related news
- FNovartis to spin off $25bn Alcon eyecare businessft.com
Novartis slims down with $25bn spin-off of Alcon eyecare businessbusinessdayonline.com
Novartis Considers Alcon Spin-OffForbes
Pharmakonzern Novartis treibt Alcon-Börsengang voranReuters
Struggling Alcon shows some progress as Novartis weighs spinoffStar Telegram- Fort Worth’s Alcon spun off Novartis, now trading on NYSEStar Telegram
- Novartis says 'never say never' to Alcon disposalReuters
- Novartis open global data center at Alcon in Fort WorthStar Telegram
Novartis Weighs Spinning Off Alcon Eye-Care Unitwsj.com- Novartis launches $5 billion share buyback, mulls Alcon spin-offReuters
- Trennung von Novartis kommt Augenheilkonzern Alcon teuer zu stehenReuters
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Actionjdsupra.com- WNovartis names drugs chief as CEOwhitecourtpress.com
- KEye Laser Surgery Device Service Market Insights – Growth, Challenges and Future Scope to 2026| Alcon (Novartis), J &J, Zeiss, Valeant, Ziemer Ophthalmic, Avedroksusentinel.com
Novartis CEO Jimenez to step down early next yearneworleanscitybusiness.com- Novartis CEO plays down prospects for Actelion bid: BlickReuters
- LGlobal Artificial Tear Liquid Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | Top Brands: Allergan, Similasan Corporation, Abbott, Alcon (Novartis), Rohto, Bausch & Lomb,…liverpoolstudentmedia.com
- KOphthalmic Lasers Therapeutic Service Market 2021- Key Strategy, Revenue, Opportunity and Key Trends -2026 | Alcon (Novartis), J &J, Zeiss, Valeant, Ziemer Ophthalmicksusentinel.com